Canoe Financial LP purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA – Free Report) during the 1st quarter, Holdings Channel reports. The fund purchased 1,285,193 shares of the company’s stock, valued at approximately $107,584,000.
Several other hedge funds have also recently bought and sold shares of the business. Vanguard Group Inc. grew its stake in Corteva by 0.4% during the 4th quarter. Vanguard Group Inc. now owns 80,536,951 shares of the company’s stock valued at $5,398,392,000 after acquiring an additional 317,538 shares in the last quarter. State Street Corp lifted its position in shares of Corteva by 3.7% in the fourth quarter. State Street Corp now owns 36,570,876 shares of the company’s stock worth $2,451,346,000 after purchasing an additional 1,290,071 shares in the last quarter. Franklin Resources Inc. lifted its position in shares of Corteva by 4.3% in the fourth quarter. Franklin Resources Inc. now owns 19,537,500 shares of the company’s stock worth $1,309,599,000 after purchasing an additional 805,873 shares in the last quarter. Harris Associates L P boosted its holdings in shares of Corteva by 168.1% during the fourth quarter. Harris Associates L P now owns 17,026,221 shares of the company’s stock worth $1,141,268,000 after purchasing an additional 10,675,052 shares during the period. Finally, Northern Trust Corp grew its position in Corteva by 5.0% during the fourth quarter. Northern Trust Corp now owns 11,731,834 shares of the company’s stock valued at $786,385,000 after purchasing an additional 562,550 shares in the last quarter. 81.54% of the stock is owned by hedge funds and other institutional investors.
Corteva Trading Down 0.0%
NYSE:CTVA opened at $82.60 on Monday. The stock’s 50 day moving average price is $79.38 and its 200 day moving average price is $76.28. Corteva, Inc. has a 52 week low of $60.53 and a 52 week high of $85.63. The company has a market capitalization of $55.24 billion, a P/E ratio of 48.59, a P/E/G ratio of 2.53 and a beta of 0.57. The company has a debt-to-equity ratio of 0.07, a quick ratio of 1.03 and a current ratio of 1.47.
Corteva Dividend Announcement
The firm also recently declared a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were issued a dividend of $0.18 per share. The ex-dividend date was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 42.35%.
Analyst Ratings Changes
CTVA has been the topic of several research reports. CICC Research upped their price objective on shares of Corteva from $80.00 to $93.00 and gave the company an “outperform” rating in a research note on Wednesday, May 13th. Royal Bank Of Canada lifted their target price on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research note on Thursday, May 7th. Jefferies Financial Group boosted their price target on shares of Corteva from $95.00 to $97.00 in a report on Thursday, May 7th. Argus upped their price target on shares of Corteva from $80.00 to $91.00 and gave the stock a “buy” rating in a research note on Tuesday, March 31st. Finally, Morgan Stanley increased their price objective on Corteva from $84.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 28th. Fourteen equities research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $88.81.
Check Out Our Latest Stock Analysis on Corteva
About Corteva
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Recommended Stories
- Five stocks we like better than Corteva
- As Stablecoins Keep Growing, These 2 Stocks Benefit
- Apple Just Handed These 4 Memory Stocks Their Best News of the Year
- Costco’s Secret Growth Engine May Be Running Out of Gas
- Why Alphabet’s Pullback May Be an Opportunity in Disguise
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
